Although the mechanisms by which VDAC1 and LDLRAP1 are involved in statin response remain to be elucidated, clinical trials in which the expression of these genes narrows down the cases of ovarian cancer will be very promising. This evidence concerns the gene LDLRAP1 and ovarian cancer.